A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

Clinical trial NCT01548287 · COMPLETED

Trial details

NCT number: NCT01548287
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment Mild Alzheimer's Disease

Start date: 2012-04-01
Primary completion: 2013-01-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.